英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
RI-2
|
1417162-36-7 |
RI-2
|
CS-1675;1-(3,4-二氯苯基)-3-(4-甲氧基苯基)-4-(4-吗啉基)-1H-吡咯-2,5-二酮;RI2;RI 2
|
C21H18Cl2N2O4 |
433.28462 | |
BMS-663068
|
864953-29-7 |
FOSTEMSAVIR
|
BMS-663068;BMS 663068;BMS663068;FOSTEMSAVIR;FOSTEMSAVIR;磷坦姆沙韦;BMS-663068;BMS 663068;BMS663068
|
C25H26N7O8P |
583.489801 | |
BMS 626529
|
701213-36-7 |
BMS 626529
|
CS-1668;1-(4-苯甲酰基哌嗪-1-基)-2-[4-甲氧基-7-(3-甲基-1H-1,2,4-三氮唑-1-基)-1H-吡咯并[2,3-C]吡啶-3-基)乙烷-1,2-二酮;BMS 626529;BMS626529
|
C24H23N7O4 |
473.48392 | |
Almorexant
|
871224-64-5 |
阿莫伦特
|
CS-1665;阿莫伦特;ACT-078573;ACT 078573;ACT078573;(2R)-2-[(1S)-6,7-DIMETHOXY-1-[2-[4-(TRIFLUOROMETHYL)PHENYL]ETHYL]-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL]-N-METHYL-2-PHENYLACETAMIDE
|
C29H31F3N2O3 |
512.56 | |
Bikinin
|
188011-69-0 |
Bikinin
|
4-[(5-溴-2-吡啶基)氨基]-4-氧代丁酸;BIKININ>98%;4-[(5-溴吡啶-2-基)氨基]-4-氧代丁酸
|
C9H9BrN2O3 |
273 | |
EPZ015666
|
1616391-65-1 |
EPZ15666
|
EPZ-015666;EPZ 015666;GSK3235025;EPZ-015666;EPZ 015666;N-[(2S)-3-(3,4-二氢-2(1H)-异喹啉基)-2-羟基丙基]-6-(3-氧杂环丁基氨基)-4-嘧啶甲酰胺
|
C20H25N5O3 |
383.4442 | |
Liproxstatin-1
|
950455-15-9 |
脂血抑素-1
|
N-[(3-氯苯基)甲基]-螺[哌啶-4,2'(1'H)-喹喔啉]-3'-胺
|
C19H21ClN4 |
340.84984 | |
SAG
|
912545-86-9 |
SAG
|
3-Chloro-N-[trans-4-(methylamino)cyclohexyl]-N-[[3-(4-pyridinyl)phenyl]methyl]- benzo[b]thiophene-2-carboxamide;SAG;3-Chloro-N-[trans-4-(MethylaMino)cyclohexyl]-N-[[3-(4-pyridinyl)phenyl]Methyl]-;SAG (cyclopamine antagonist);SAG (Smo agonist);3-chloro-N-((1r,4r)-4-(methylamino)cyclohexyl)-N-(3-(pyridin-4-yl)benzyl)benzo[b]thiophene-2-carboxamide;Smoothened Agonist (SAG) free base;Smoothened Agonist (SAG) HCl
|
C28H28ClN3OS |
||
GW 627368X
|
439288-66-1 |
GW 627368X
|
CS-1654;GW 627368;GW-627368;GW627368;GW-627368X;GW627368X;GW 627368X
|
C30H28N2O6S |
544.61812 | |
Carbonic Anhydrase IX/XII Inhibitor II(U-104)
|
178606-66-1 |
U-14
|
CS-1653;NSC-213841;MST-104;U104;U 104;U-104>98%;U-104;NSC 213841;U 104;4-[[[(4-氟苯基)氨基]羰基]氨基]苯磺酰胺
|
C13H12FN3O3S |
309.316083 | |
TCS 5861528
|
332117-28-9 |
TCS 5861528
|
CS-1651;CHEMBRIDGE-5861528;TCS-5861528;TCS5861528;TCS 5861528;TCS-5861528;TCS5861528
|
C19H23N5O3 |
369 | |
Decernotinib
|
944842-54-0 |
地诺替尼
|
CS-1650;VX-509;VRT-831509;VX-509;VRT-831509;ADELATINIB
|
C18H19F3N6O |
392.37827 | |
6-fluoro-N-(4-fluorobenzyl)quinazolin-4-aMine
|
1262888-28-7 |
Spautin-1抑制剂
|
SPAUTIN-1;SPAUTIN1;4-((4-氟苄基)氨基)-6-氟喹唑啉;SPAUTIN-1抑制剂;6-氟-N-(4-氟苄基)喹唑啉-4-胺
|
C15H11F2N3 |
271.264746 | |
NS 6180
|
353262-04-1 |
NS 618
|
4-[[3-(三氟甲基)苯基]甲基]-2H-1,4-苯并噻嗪-3(4H)-酮
|
C16H12F3NOS |
323.33279 | |
5'-O-[(4-Cyanophenyl(methyl]-8-[[(3,4-dichlorophenyl(methyl]amino]-adenosine
|
1134156-31-2 |
VER 1558
|
CS-1647;VER 155008;VER-155008;VER155008;5'-O-[(4-氰基苯基(甲基]-8-[[(3,4-二氯苯基(甲基]氨基]腺苷
|
C25H23Cl2N7O4 |
556.40062 | |
Fruquintinib
|
1194506-26-7 |
呋喹替尼
|
呋喹替尼;呋喹替尼;呋喹替尼(HMPL-013);6-(6,7-二甲氧基喹唑啉-4-氧代)-N,2-二甲基苯并呋喃-3-甲酰胺
|
C21H19N3O5 |
393.39266 | |
TP-0903
|
1341200-45-0 |
TP-93
|
CS-1642;2-[[5-氯-2-[[4-[(4-甲基-1-哌嗪基)甲基]苯基]氨基]-4-嘧啶基]氨基]-N,N-二甲基苯磺酰胺;TP 0903;TP0903;DUBERMATINIB
|
C24H30ClN7O2S |
516.0587 | |
Debio-1347
|
1265229-25-1 |
DEBIO-1347
|
CS-1637;CH5183284;CH-5183284;CH 5183284
|
C20H16N6O |
356.38064 | |
GSK5959
|
901245-65-6 |
GSK5959
|
|
C22H26N4O3 |
394.46684 | |
UNC 0224
|
1197196-48-7 |
UNC 224
|
7-[3-(二甲基氨基)丙氧基]-2-(六氢-4-甲基-1H-1,4-二氮杂卓-1-基)-6-甲氧基-N-(1-甲基-4-哌啶基)-4-喹唑啉胺
|
C26H43N7O2 |
485.66532 |